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Objective: Our goal was to generate a preoperative risk-of-death predic-
tion model in selected neonates with congenital heart disease undergo-
ing surgery with deep hypothermic circulatory arrest. Methods: We com-
pleted a single-center, prospective, randomized, double-blind, placebo-
controlled neuroprotection trial in selected neonates with congenital
heart disease requiring operations for which deep hypothermic circula-
tory arrest was used. An extensive database was generated that includ-
ed preoperative, intraoperative, and postoperative variables. Variables
(delivery, maternal, and infant related) were evaluated to produce a pre-
operative risk-of-death prediction model by means of logistic regression.
An operative risk-of-death prediction model including duration of deep
hypothermic circulatory arrest was also generated. Results: Between July
1992 and September 1997, 350 (74%) of 473 eligible infants were
enrolled with 318 undergoing deep hypothermic circulatory arrest. The
mortality was 52 of 318 (16.4%), unaffected by investigational drug. The
resulting preoperative risk model contained 4 variables: (1) cardiac
anatomy (two-ventricle vs single ventricle surgery, with/without arch
obstruction), (2) 1-minute Apgar score (≤5 vs >5), (3) presence of genet-
ic syndrome, and (4) age at hospital admission for surgery (≤5 or >5
days). Mortality for two-ventricle repair was 3.2% (4/130). Mortality for
single ventricle palliation was 25.5% (48/188) and was significantly
influenced by Apgar score, genetic diagnosis, and admission age. The
preoperative model had a prediction accuracy of 80%. The operative
risk model included duration of deep hypothermic circulatory arrest,
which significantly (P = .03) increased risk of death, with a prediction
accuracy of 82%. Conclusions: In this selected population, postoperative
mortality risk is significantly affected by preoperative conditions.
Identification of infants with varying mortality risks may affect family
counseling, therapeutic intervention, and risk stratification for future
study designs. (J Thorac Cardiovasc Surg 2000; 119:347-57)
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M ore than one third of the 30,000 infants with con-genital heart disease (CHD) born in the United
States each year require surgical intervention in early
infancy.1-3 The factors that influence immediate post-
operative mortality are not completely understood.
Many previous investigations have focused primarily
on specific anatomic entities, the contributions of dif-
ferent surgical techniques, and the conduct of cardiac
anesthesia. For many forms of CHD, heart surgery in
the neonate necessitates both cardiopulmonary bypass
(CPB) and deep hypothermic circulatory arrest
(DHCA), which may independently confer time-depen-
dent risks.4,5 The durations of CPB and DHCA them-
selves are dependent on the complexity of the defective
anatomy, the medical status of the infants, and the skill
of the surgeon. Consequently, the risk contributions
attributed to CPB and DHCA are difficult to quantify.
The immediate modes of death after heart surgery in
the neonate are generally known and include cardiac
arrhythmias, shock, hemorrhage, and sepsis. However,
a comprehensive method of quantifying preoperative
mortality risks is not available. This study was con-
ducted to determine whether preoperative characteris-
tics could be identified that significantly affect mortal-
ity and to examine their relative contribution to death
risk. The final purpose was to formulate a simple,
broadly applicable risk-of-death prediction model
across the spectrum of CHD. 
Methods
Study population. Newborn infants admitted to the
Cardiac Center of The Children’s Hospital of Philadelphia
from July 1992 to September 1997 for evaluation of CHD
were screened for enrollment into a pharmacologic neuropro-
tection trial, the context in which the preoperative risk-of-
death models were developed. The study was conducted as a
single-center, stratified, randomized, blinded, placebo-con-
trolled trial with study drug administered before, during, and
after heart surgery with DHCA in the neonate.
Infants were enrolled in the trial and consequently were the
target population of the risk model building if they satisfied
the following criteria: congenital heart defect necessitating an
operation in which DHCA was the chosen perfusion strategy;
conceptional age* less than 45 weeks; absence of coincident
lethal genetic disorders or severe multiple congenital abnor-
malities; and informed consent provided. Infants were
excluded for the following reasons: neurologic unassessabli-
ty (from neuromuscular blockade), seizures or coma, elevat-
ed liver function tests, neutropenia, or if enrollment would
have occurred less than 16 hours before the operation. The
study protocol was approved by the Committee for the
Protection of Human Subjects. 
William I. Norwood and Marshal L. Jacobs performed the
operations during approximately the first half of the trial and
Thomas L. Spray and J. William Gaynor performed the
remainder. The surgical techniques were not standardized,
although the Norwood procedure was performed for patients
with hypoplastic left heart syndrome and single ventricle.
Cardiac anesthesia was uniformly maintained during the trial,
including alpha-stat acid-base management.
Data collection. A comprehensive database was generated,
including clinical observations, laboratory values, imaging
examinations, and neurodevelopmental test results. The data-
base was temporally organized into three periods: (1) preop-
erative, (2) intraoperative, and (3) postoperative.
Preoperative observations. The general categories of pre-
operative information examined are provided in Table I.
Categories were chosen because of their plausible relation-
ship to survival and neurologic outcome and the reliable qual-
ity of the data. Preoperative observations included demo-
graphic data, maternal/fetal characteristics of gestation, and
labor and delivery. Demographic data included mother’s race,
age, parity, socioeconomic status (Hollingshead index6), and
the presence of maternal health conditions. Characteristics of
the infants included gestational age, birth weight, sex, Apgar
scores, age at admission to The Children’s Hospital of
Philadelphia, microcephaly (head circumference ≤ 2nd per-
centile for age), and the presence of a genetic or chromoso-
mal syndrome. Diagnoses were based on a clear constellation
of clinical findings to name a specific genetic syndrome (eg,
Goldenhar) or abnormal chromosomal analysis (eg, 22q11
deletion). Other infants had definite dysmorphic features (eg,
cleft palate) but not a specific, named genetic syndrome. The
medical status of the heart, lungs, kidneys, liver, gastroin-
testinal tract, and bone marrow was also recorded.
The congenital heart defects of the infants were classified
into 1 of 4 categories on the basis of preoperative echocar-
diograms: class I, two-ventricle heart without arch obstruc-
tion; class II, two-ventricle heart with arch obstruction; class
III, single ventricle heart without arch obstruction, and class
IV, single ventricle heart with arch obstruction.
Intraoperative and postoperative observations. Character-
istics of the intraoperative period included the duration of
surface cooling, lowest recorded nasopharyngeal tempera-
ture, duration of CPB cooling, DHCA time, duration of
rewarming on CPB, need for additional CPB, and the use of
modified ultrafiltration. Postoperative clinical end points for
the neuroprotection trial were recorded during the intensive
care unit stay, not to exceed 6 weeks after the operation.
Observations included the occurrence of death, seizures,
coma, and cardiac events.
Statistical considerations. The study population is char-
acterized by the number of infants available for each variable,
means and standard deviations for continuous data, and fre-
quencies and proportions for categorical data. Exact 95%
confidence intervals are presented for some proportions. 
Model building was iterative, integrating clinical knowl-
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*Age since conception is determined by adding legal age (time from
birth) to estimated gestational age (eg, the conceptional age of a 3-
week-old, 37-week estimated gestational age infant is 40 weeks).
edge and results of statistical analyses, with the intent of cre-
ating a broadly applicable parsimonious model. Because
there were 52 deaths in the database it was determined a pri-
ori that a maximum of 5 prediction variables (10:1 ratio)
would be allowed in the final preoperative risk prediction
model. The logistic regression model7 was used for selecting
variables and characterizing their strength of associations
with death, using the odds ratio and 95% confidence inter-
vals. Logistic regression models the proportion of deaths and
how these proportions are influenced by predictor variables.
Mean values were substituted for candidate predictor vari-
ables with 5% or fewer missing values. 
Categorical variables were formatted with the use of cus-
tomary dummy variables structure. Dichotomous variables
were coded as zero and one, with zero being the reference
category. For exploration of initial models, ordinal and con-
tinuous (interval scaled) scaled data from the entire data set
(Table I) were evaluated as collected or transformed by
means of the natural logarithm for continuous data. Sums of
binary variables representing maternal and infant infections,
ischemic conditions, and cardiac, metabolic, and neurologic
conditions (Table I) were evaluated for their association with
death, as well as the individual binary variables. Stepwise
logistic regression (entry P values of .25, P value to stay of
.1) was used to facilitate and verify the final model selection
of variables; however, statistical knowledge gained through
separate analyses and clinical knowledge guided the selection
process. Continuous variables that were strongly considered
for model selection were also evaluated on the basis of quar-
tiles. Strong statistical support and/or a clear clinical rationale
for inclusion of variables into the final preoperative predic-
tion model were required.
Model fit was determined by means of the Hosmer and
Lemeshow8 method, and the deviance method was used for
dispersion correction. The area under the receiver operating
characteristic (ROC) curve is a measure of the overall predic-
tion accuracy of the logistic model and, with its associated
standard error,9-11 was used to evaluate different models. The
ROC curve is a graphic way of presenting separations
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Table I. Preoperative variables examined
Demographics Newborn characteristics Maternal characteristics Early neonatal course 
(n = 3) (n = 13) (n = 11) (n = 23)
Race Birth weight Chronic circulatory Toxic-metabolic-infectious
Sex Gestational age Anemia Hypoglycemia and hyperglycemia
Hollingshead score Size for dates Hypertension Hyponatremia and hypernatremia
Delivery mode: Pre-eclampsia Hypomagnesemia and hypermagnesemia
cesarean section vs vaginal Diabetes Infection (eg, sepsis, meningitis, pneumonia)
Apgar score at 1 min Placental insufficiency Necrotizing enterocolitis 
Apgar score at 5 min Infection Liver dysfunction
Delivery room resuscitation Urinary tract Renal dysfunction
Meconium passage/staining Sexually transmitted diseases Cardiorespiratory-circulatory
Microcephaly Chorioamnionitis Age at hospital admission
Genetic syndrome or Drug exposure Metabolic acidosis
chromosomal abnormality Alcohol Cardiac or respiratory arrest
Family history of seizures/ Tobacco Congestive heart failure
cerebral palsy Illicit drugs Anatomic class of CHD (class I, II, III, or IV)
Oligohydramnios Blood pressure instability/shock
Polyhydramnios Respiratory insufficiency
Pneumothorax
Assigned cardiothoracic surgeon (S1, S2, S3, S4)
Neurologic
Hydrocephalus
Brain infarction
Brain hemorrhage
Hypotonia
Lethargy
Hypothermia
Table II. Patient disposition summary
N Percent
Enrolled 350 100.0
Reason excluded
No operation 8 2.3
No DHCA 24 6.9
DHCA population 318 90.9
Not enrolled 123 100.0
Reason not enrolled
Consent denied 57 46.3
Immediate operation 62 50.4
Immediate death 3 2.4
Other 1 0.8
between two groups and is a plot of percent of deaths pre-
dicted to die versus percent of survivors predicted to die. This
curve is generated by creating a frequency distribution of
model-generated predicted probabilities and by using each of
the observed predicted probabilities as a threshold for classi-
fication. For a given threshold value (predicted probability),
all cases above the threshold are classified as a death, yield-
ing the percent of those that died who were predicted to die
and the percent of survivors predicted to die in survivors.
Allowing the threshold to assume all observed predicted
probabilities results in the ROC curve. The area under this
curve is a measure of the probability that given a randomly
selected case from the survivor group (N = 266) and a ran-
domly selected case from the death group (N = 52), the case
from the death group will be assigned a higher predicted
probability of death. This measure is independent of the prior
probability of death and is considered to represent accuracy
of the prediction model. The area is provided on the basis of
the fitted model using all of the data and using an approxi-
mate jackknife12 procedure, which provides predicted proba-
bilities of death for each case, based on fitting the model with
the remaining cases. The jackknife provides a conservative
estimate of accuracy when using the same data set to create a
model and estimate its accuracy. An exact logistic regression
model was also fit to the preoperative variables. 
The primary intent of the operative model was to evaluate
the independent contribution of the duration of DHCA on
death, adjusted for the variables in the preoperative model. 
A risk stratification model was developed on the basis of
the percent of deaths in each of the 18 (of a possible 24)
unique combinations (profiles) of independent predictor vari-
ables represented in the preoperative logistic model. This
model contains the information presented in the logistic
model, but in a more clinically useful manner. The preopera-
tive predictor variables will also be referred to as risk factors.
SAS (SAS Institute, Cary, NC) and LogXact (Cytel
Software, Cambridge, Mass) software were used for all sta-
tistical analyses. All reported P values are 2-sided.
Results
Study population. A patient disposition summary is
provided in Table II. A total of 350 infants were
enrolled in the study from June 1992 until September
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Table III. Demographic and selected preoperative characteristics (N = 318)
N Percent
Sex
Male 186 58.5
Female 132 41.5
Ethnicity
White 242 76.1
African American 46 14.5
Hispanic 15 4.7
Other 15 4.7
Delivery room resuscitation 138 43.4
Microcephaly 27 8.5
Specific genetic syndrome 28 8.8
Dysmorphism (no syndrome) 56 17.6
Mean ± SD Median Q1, Q3
Gestational age (wk) 318 38.5 ± 2.2 39.0 38, 40
Birth weight (kg) 309 3.1 ± 0.6 3.2 2.8, 3.6
Admission age (d) 318 2.0 1, 5
Apgar score at 1 min 301 7.5 ± 1.6 8.0 7, 8
Apgar score at 5 min 301 8.5 ± 1.1 9.0 8, 9
Hollingshead score 311 37.7 ± 17.3 39.0 27, 53
Q1, Lower quartile (25%); Q3, upper quartile (75%).
Table IV. Distribution of genetic syndromes (N = 318)
Final diagnosis N Percent
CHARGE 1 0.3
Goldenhar 3 0.9
Turner 2 0.6
VACTERL 4 1.3
Velocardiofacial 1 0.3
22q11 deletion 9 2.8
Dicentric 22 1 0.3
Trisomy 7 1 0.3
Trisomy 21 5 1.6
Trisomy 13 1 0.3
Total 28 8.8
CHARGE, Coloboma, heart disease, atresia choanae, retarded growth and
retarded development and/or central nervous system anomalies, genital
hypoplasia, and ear anomalies and/or deafness; VACTERL, vertebral abnor-
malities, anal atresia, cardiac abnormalities, tracheoesophageal fistula and/or
esophageal atresia, renal agenesis and dysplasia, and limb defects.
1997; however, 32 infants did not undergo surgery (n =
8) or DHCA (n = 24). Consequently, 318 infants were
used to generate the risk model. There were 123 infants
eligible for the study but not enrolled by reason of
denied consent (57; 46%), surgery before the 16-hour
preoperative treatment window (62; 50%), immediate
death (3; 2%), and other reason (1; 0.8%). Mortality in
eligible nonenrolled subjects was 25.2%.
Demographics and preoperative characteristics are
provided in Table III. The study population was pre-
dominantly full term, appropriate weight for gestation-
al age, and white. Apgar scores were available in 301
subjects, with mean values of 7.5 at 1 minute and 8.5 at
5 minutes, with 43% receiving some form of delivery
room resuscitation other than simple tactile stimulation
and blow-by oxygen. Admission occurred at an average
age of 5.6 days. Two hundred ninety-six (93.1%) of
patients underwent surgery before 28 days after birth.
Microcephaly occurred in 9%, dysmorphism in 18%,
and definite genetic syndromes in 9% (Tables III and
IV). The distribution of cardiac defects, their associated
mortality, and anatomic classes are shown in Table V.
Intraoperative characteristics of the study population
are provided in Table VI. The mean CPB cooling time
was 11.8 minutes, mean DHCA time was 53.7 minutes,
and mean duration of CPB rewarming was 27.3 min-
utes. Additional periods of CPB were used in 14% and
modified ultrafiltration was performed in 24%.
Mortality. The overall mortality was 16.4% (52/318)
and was unaffected by study year or investigational
drug administration. Mortality was similar for classes
III (25%; 2/8) and IV (25.6%; 46/180), which were
therefore combined as a “single ventricle” group.
Mortality in class I was 1% (1/102), in class II it was
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Table V. Distribution of cardiac defects, anatomic classification, and death by defect
Death
Type of defect Anatomic class N Percent N Percent
HLHS IV 131 41.2 35 26.7
Single ventricle IV 40 12.6 7 17.5
Heterotaxy III and IV 10 3.1 3 30.0
TGA/intact ventricular septum I 36 11.3 0 0
TGA/VSD I 13 4.1 0 0
TGA/VSD, CoAo I 1 0.3 0 0
ToF alone I 13 4.1 1 7.7
ToF/PA I 11 3.5 0 0
ToF (other) I 5 1.6 0 0
VSD/CoAo II 12 3.8 1 8.3
VSD/interrupted aortic arch II and III 14 4.4 1 7.1
VSD (other)* I, II, and III 9 2.8 1 11.1
Truncus arteriosus I 7 2.2 0 0
TAPVR I 6 1.9 0 0
Other I, II, III, and IV 10 3.1 3 30.0
Total 318 52 16.4
HLHS, Hypoplastic left heart syndrome; TGA, transposition of the great arteries; VSD, ventricular septal defect; CoAo, coarctation of the aorta; ToF, tetralogy of
Fallot; PA, pulmonary atresia; TAPVR, total anomalous pulmonary venous return.
*Includes double-outlet right ventricle (n = 3), double-outlet left ventricle (n = 1), double-outlet right ventricle/subaortic stenosis/coarctation of the aorta (n = 1), and
ventricular septal defect (n = 4).
Table VI. Intraoperative characteristics
N Mean ± SD 
Surface cooling time (min)* 318 68.1 ± 20.5
CPB cooling time (min)† 318 11.8 ± 7.4
DHCA time (min) 318 53.7 ± 15.2
First CPB rewarming time (min)† 318 27.3 ± 13.6
Percent
Need for additional CPB‡ 45 14.2
Modified ultrafiltration performed 77 24.2
*Surface cooling time = ambient room temperature, cooling blanket, ice bags
applied to head.
†Includes only the time the pump is running (excludes DHCA time).
‡Attempt to wean from CPB.
Table VII. Day of death after surgery
Day of death N Percent
Day of surgery 19 36.5
Day after surgery 9 17.3
Day 3 through day 7 7 13.5
Day 8 through day 14 13 25.0
Day 15 through day 35 4 7.7
Total 52 100.0
10.7% (3/28), and in classes III and IV it was 25.5%
(48/188). Death occurred rapidly in the study popula-
tion (Table VII). All deaths occurred within 30 days of
the operation except for one that occurred on day 35.
Logistic regression models. Four preoperative vari-
ables were significantly associated with death: anatom-
ic classification, 1-minute Apgar score, genetic syn-
drome, and age at hospital admission. Table VIII
352 Clancy et al The Journal of Thoracic and
Cardiovascular Surgery
February 2000
Table VIII. Distribution of four identified preoperative characteristics
Mortality
Characteristics N % N %
Congenital heart disease classification
Class I 102 32.1 1 1.0
Class II 28 8.8 3 10.7
Class III 8 2.5 2 25.0
Class IV 180 56.6 46 25.6
Genetic syndrome
None 234 73.6 30 12.8
Dysmorphism 56 17.6 14 25.0
Genetic syndrome 28 8.8 8 28.6
Apgar score at 1 minute
≤5 33 10.4 11 33.3
>5 285 89.6 41 14.4
Age at hospital admission (d)
≤5 239 75.2 35 14.6
>5 79 24.8 17 21.5
Table IX. Risk of death based on the logistic regression model: Preoperative and operative
Odds ratio
Model Parameter estimate Asymptotic Exact Odds ratio* (95% CI) P value
Preoperative model (prediction accuracy = 80%)
Intercept —5.6549
Anatomy
Class II 2.6896 14.7‡ 13.6‡ 1.6-134.0 .02
Class III + IV 4.1054 60.7‡ 53.5‡ 8.5-433.5 .0001
Genetic syndrome 1.8317 6.2§ 6.0§ 2.1-18.4 .001
Apgar score ≤ 5 1.3821 4.0II 3.9II 1.7-9.5 .002
Age at admission > 5 days 0.6547 1.9¶ 1.9¶ 1.0-3.8 .06
Operative model (prediction accuracy = 82%)
Intercept —5.9021
Anatomy
Class II 2.4580 11.7‡ 1.4-94.7 .02
Class III + IV 3.8075 45.0‡ 7.1-286.9 .0001
Genetic syndrome 1.7681 5.9§ 2.1-16.3 .001
Apgar score ≤ 5 1.2849 3.6II 1.5-8.4 .003
Age at admission > 5 days 0.6958 2.0¶ 1.1-3.8 .03
DHCA time†
44 to 52 min 0.3063 1.4# 0.5-3.9 .57
53 to 62 min 0.3894 1.5# 0.6-4.0 .44
>62 min 1.0308 2.8# 1.1-7.1 .03
*Wald confidence limits.
†DHCA time = duration of deep hypothermic circulatory arrest.
‡Compared with class I anatomy.
§Compared with no genetic syndrome.
IICompared with an Apgar score > 5.
¶Compared with age at admission ≤ 5 days.
#Compared with < 44 minutes.
provides the proportions of infants with these charac-
teristics. The preoperative logistic model results (good-
ness of fit, P = .9) are presented in Table IX and the
corresponding ROC curve is provided in Fig 1, which
yields an accuracy of 80% (standard error of 2.8%).
However, the accuracy of the jackknife ROC curve was
70%.
An operative risk-of-death model (goodness of fit, P
= .9) was also developed (Table IX) to evaluate the
independent contribution of DHCA duration. The 4th-
quartile DHCA duration (>62 minutes) was associated
with a significant increase in the odds of death (odds
ratio [OR] = 2.8; P = .03). The accuracy (area under the
ROC curve) increased to 82% (standard error of 2.7%)
by including DHCA duration.
Fig 2 provides a clinically relevant risk stratification
tree with 6 terminal nodes (N1 to N6) into which all
318 study subjects are assigned on the basis of the 4
preoperative variables. The lowest percentage of death
(1%; 1/102) was in node N1, characterizing infants
with class I anatomy. Class II anatomy defines node N2
with a 10.7% (3/28) mortality. Combined classes III
and IV had the highest mortality (25.5%; 48/188).
Within this group, a 1-minute Apgar score of 5 or less
(node N3) was associated with a significantly increased
mortality (55.0%; 11/20) compared with those with
higher Apgar scores (22.0%; 37/168). In node N4 the
mortality for single ventricle infants with Apgar scores
more than 5 and a genetic syndrome (55.6%; 5/9) was
significantly higher than for those without a genetic
diagnosis (20.1%; 32/159). Terminal nodes N5 and N6
show the effects of “age at admission” on infants with
no genetic syndrome and an Apgar score more than 5.
“Age at admission more than 5 days” was associated
with higher mortality (31.6%; 12/38) than that of
patients admitted before 5 days (16.5%; 20/121).
Finally, survival of single ventricle infants with favor-
able Apgar scores, genetics, and admission age was
83.5%.
Another summary of the risk-of-death stratification is
provided in Table X, with mortality risk ranging from
1.0% to 55%, depending on the CHD anatomic classi-
fication and the presence of risk factors.
Discussion
This study identified preoperative variables that were
significantly associated with an increased risk of death
after surgery. Death has always been intimately con-
nected to the presence of CHD. Until recent decades,
most severely affected infants with CHD died soon
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Fig 1. Preoperative risk-of-death logistic regression model ROC curve. Nonparametric area under ROC curve =
80%; standard error of the area = 2.8%.
after birth or survived tenuously with chronic cyanosis,
congestive heart failure, failure to thrive, and psy-
chomotor delay. With the development of the technolo-
gy used in cardiothoracic surgery, much attention has
been focused on innovative surgical techniques and
refining neonatal CPB, DHCA, and modified ultrafil-
tration. The immediate modes of postoperative death
are known and include myocardial failure, shock, hem-
orrhage, arrhythmias, systemic/pulmonary circulatory
mismatch, and coronary artery insufficiency. However,
knowing the circumstances surrounding death does not
allow preoperative risk stratification. The purpose of
this investigation was to attempt to identify preopera-
tive variables that may be associated with immediate
postoperative death. Estimating the strength of these
associations and creating a risk stratification model
were additional objectives. These goals were chosen
since relatively few studies have examined the pre-
existing condition of infants before cardiac surgery,13-20
and none has produced a risk-of-death prediction
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Fig 2. Preoperative risk of death stratification model with associated model predicted probabilities of death. P
represents the average of all node-predicted probabilities. OR, Odds ratio.
Table X. Preoperative risk of death stratification
Class N Deaths Risk of death (%) 95% CI* (%)
I. Dual ventricle without arch repair 102 1 1.0 0.0-5.3
II. Dual ventricle with arch repair 28 3 10.7 2.3-28.2
III and IV. Single ventricle 188 48 25.5 19.5-32.4
3a. No risk factors† 121 20 16.5 10.4-24.4
3b. Greater than 5-day admission (only) 38 12 31.6 17.5-48.7
3c. Genetic syndrome or low Apgar score 29 16 55.2 35.7-73.6
3d. Any risk factor† 67 28 41.8 29.9-54.5
*Exact binomial.
†Risk factors are genetic syndrome, Apgar score < 5, and age at admission > 5 days.
model. Limperopoulos and associates13 reported the
presence of microcephaly (occipitofrontal circumfer-
ence < 3rd percentile) in 35.7% of 56 neonates before
heart surgery and clinical neurologic abnormalities (eg,
poor suck or low tone) in 28 of 50 (56%) infants exam-
ined. In the study by Newburger and colleagues,17 pre-
operative examinations showed definite clinical neuro-
logic abnormalities in 55 of 152 (36.2%) infants before
the operation. In the present study, infants frequently
had low 1-minute Apgar scores, delivery room resusci-
tation, genetic syndromes, dysmorphic features, and
microcephaly. Consequently, it is reasonable to seek
clues regarding postoperative mortality among preop-
erative characteristics.
The mortality in this study (Table V) is comparable
with that of other published series, ranging from 26%
for single ventricle lesions, including hypoplastic left
heart syndrome, to 3.2% for all other forms of complex
neonatal heart disease.17,21,22 The proportion of deaths
in the eligible, nonenrolled patients (25.2%) was sig-
nificantly (P = .01) higher than that of enrolled infants
(16.4%). This was attributed mostly to the urgent need
for surgery and immediate death in over half of the
nonenrolled infants (Table II).
Not surprisingly, cardiac anatomy was a powerful
preoperative predictor of mortality. There are specific
anatomic variants within diagnostic groups that
increase mortality risk. Examples are hypoplastic left
heart syndrome with intact atrial septum or transposi-
tion of the great arteries with intramural coronary arter-
ies. This speculative risk model uses a broad anatomic
and physiologic classification scheme that was simple
and easy to apply to individuals or classes of infants
with CHD. 
The presence of a specific named genetic syndrome
was the second most potent modulator of risk of death.
Abnormalities of chromosome 22, reported with about
5% of CHD,23 occurred in 3.5% (11/318) of study sub-
jects. “Dysmorphism,” present in 18% of other study
infants, was also associated with a trend to increased
risk of death (OR = 1.963; P = .11). This suggests that
increased mortality risk is not confined to a single
genetic condition but is associated with any dysmor-
phic or genetic condition. This agrees with Bove’s
observation24 that mortality in patients with hypoplas-
tic left heart syndrome was significantly increased by
noncardiac congenital conditions.
Apgar scores can be lowered by asphyxia, sepsis,
shock, CHD, medications, and neurologic disorders.
Depressed 5-minute Apgar scores traditionally corre-
late with morbidity such as cerebral palsy.25-27 In this
study, low 1-minute Apgar scores were present in 10%
of the population and were associated with increased
mortality, perhaps indicating that the CHD prevented a
smooth circulatory transition from intrauterine life or
that the CHD had already introduced a neurologic dis-
order. 
Older age at admission was associated with a higher
risk of death (OR = 1.9; P = .06 in the preoperative
model; OR = 2.0; P = .03 in the operative model). The
influence of age at admission on mortality was inde-
pendent of prostaglandin administration and other pre-
operative characteristics. The mechanism by which age
at admission affects mortality risk is unknown. 
This study has several important strengths. It is com-
prehensive in its scope of CHD, includes a wide range
of anatomic lesions, and reflects the experience of four
cardiothoracic surgeons over a 5-year period. It is intu-
itively appealing that cardiac anatomy, Apgar scores,
and genetic syndromes could be associated with an
increased risk of death. The relative joint contribution
of each variable to mortality was quantified in terms of
odds ratios and segments the population into subgroups
of varying risks. This variation in risk is considerable.
For example, survival of patients with single ventricle
complex with favorable genetics, Apgar score, and age-
at-admission status was 83.5% (Table X, 3a), compared
with 44.8% (Table X, 3c) in high-risk patients. After
adjustment for the predictive preoperative variables,
the length of DHCA time was associated with mortali-
ty risk. Those infants requiring between 44 and 62 min-
utes of DHCA had an odds ratio of approximately 1.5,
and those requiring more than 62 minutes had an odds
ratio of 2.8, compared with infants needing less than 44
minutes of DHCA.
The study also has important limitations. The risk
model reflects the population from which it was
derived—a selected group of neonates who underwent
heart surgery with DHCA after fulfilling specific inclu-
sion criteria for the neuroprotection trial. Unknown
patient selection biases may exist, and the distribution
of CHD lesions in this group is heavily weighted to sin-
gle ventricle complexes. Although internally consis-
tent, the risk-of-death model is speculative, has not
been validated on an independent population, and prob-
ably exaggerates its predictive abilities. With the use of
the jackknife method of generating the predicted prob-
ability of death, the ROC curve was constructed to
measure the potential over-optimism of the regression
model, and the resulting prediction accuracy fell to
70%. Finally, great care should be exercised when con-
sidering the application of this information to an indi-
vidual infant with CHD. The 95% confidence intervals
show a substantial range of mortality risk values, espe-
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cially in single ventricle lesions (Table X). Such infor-
mation could be useful for counseling families of
neonates awaiting heart surgery and for accommodat-
ing risk factors in future therapeutic interventional tri-
als in this patient population. 
In conclusion, it is important to acknowledge that the
preoperative condition of these infants had a profound
effect on survival. Potent predictors of mortality
already exist before the operation commences.
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Discussion
Mr Marc R. de Leval (London, United Kingdom). I com-
mend Dr Clancy and his colleagues for a well-conducted
prospective study. The criteria of enrollment and the end
points were well defined, and their very large data set was
submitted to highly sophisticated statistical analysis. The
demonstration that in a subset of high-risk patients, namely
patients with a single ventricle, the strongest predictors of
death were preoperative variables is extremely important.
Traditionally, outcome analyses have concentrated on com-
paring intraoperative procedural variables, for example,
DHCA, against hypothermic CPB, disregarding the preoper-
ative variables. The objective of this study was to generate a
prediction model of early deaths. The findings should help
the authors to secure resources to extend similar studies to the
late outcomes and to investigate the impact of those preoper-
ative variables on late sequelae such as neurologic deficits
and developmental delays. 
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I have two questions. You indicated that 123 patients did
not fulfill the criteria of enrollment, and the mortality in that
subset of patients was significantly higher than that in the
patients you have analyzed. Is it conceivable that by exclud-
ing those patients you lost the opportunity to identify other
predictors of death? 
Second, I understand that the operations were performed
by two surgeons doing the first phase of the study and two
others doing the second phase of the study and that the results
were similar for all those surgeons. Without trying to dimin-
ish the role of the surgeons, I would like to ask whether you
believe that the system or the institutions in which they work
is more important than the individual surgeons in the produc-
tion of excellence? 
Dr Clancy. I thank you for those comments, Mr de Leval.
The first question concerned the effect of the nonenrolled
patients. The children in the nonenrolled group who died
were not predominantly the single ventricle patients but
rather those who had something critical about their anatomy
that precluded their waiting for 16 hours. The mortality in
nonenrolled patients who would have been in classes III and
IV was the same as that in the enrolled patients in classes III
and IV. The differences really came out in the more critical
cases. From that point of view, what would have otherwise
been a lower mortality in classes I or II could have been
raised. However, with class I used as the reference point, those
differences would not have violated the broad categorizations. 
Part of the difficulty is whether to be “lumpers” or “split-
ters.” I am sure that surgeons could give me, a neurologist,
many examples of what should and should not be included in
any one of these groups, but painting with a broad stroke kept
this study fairly simple. 
The second question concerns the importance of the sur-
geon versus the institution. We wanted to make a generaliz-
able model, something that would not be institution-specific,
predicting the results of a surgeon or a group of surgeons.
However, the whole team really produces these results. For
example, we have had the same cardiothoracic anesthesiolo-
gists at Children’s Hospital for the whole series, and I think
that is part of the reason why these numbers are as good as
they are. Whether this factor can be applied to another insti-
tution, I do not know. It is always tempting to think that one’s
expertise is the reason for the good results, but much of what
is going to happen to the patient is predetermined by the
genetics and the condition of the child on admission to the
hospital. 
This is a speculative model derived from the data that we
generated, so of course it fits our data. The question is
whether it will hold up if we test it independently in another
set of patients in another institution with different anesthesi-
ologists and different surgeons. Testing this model on an
independent data set of children is one of the jobs ahead of
us. The reason it is consistent in our study is that it is derived
from our own data. 
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